
NYSE:CVS
This summary was created by AI, based on 9 opinions in the last 12 months.
CVS Health Corp has recently experienced a notable turnaround, with a significant rise in its stock price following an earnings beat and an increase in its full-year forecast. Analysts indicate that while the stock may appear undervalued at first glance, caution is advised due to the visibility issues in its quarter-to-quarter performance. The company, more focused on managed care rather than just pharmacy operations, has shown impressive revenue growth, particularly in its health insurance segment, despite challenging conditions in the retail pharmacy space. With a trading price that reflects low valuation multiples and the potential for further upside, CVS is considered a viable option for investors looking at the healthcare sector, especially given the positive management changes and the ongoing momentum in its business segments.
(Market Call Minute) drugstore and a pharmacy benefit manager and they are clicking along on all cylinders.